BIOA Competitors & Alternatives

Compare BioAge Labs, Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BIOA

Main Stock
$6.61
Tradestie Score
39
Market Cap
$212.23M
Revenue Growth
0.0%
Analyst Upside
+439.0%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
ZBIO Zenas BioPharma, Inc. Common Stock
$28.30
$931.48M - 67 Compare
MBX MBX Biosciences, Inc. Common Stock
$58.51
$800.41M - 57 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.55
$711.32M - 67 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$55.36
$543.32M 133.3 61 Compare
GLUE Monte Rosa Therapeutics, Inc. Common Stock
$10.50
$463.20M - 42 Compare
ALMS Alumis Inc. Common Stock
$6.85
$422.50M - 49 Compare
EOLS Evolus, Inc. Common Stock
$7.14
$397.82M - 42 Compare
KYTX Kyverna Therapeutics, Inc. Common Stock
$6.22
$258.18M - 41 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.64
$237.15M 5.0 60 Compare

Data updated: Oct 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry